Vaccine Formulation and Manufacturing for High-Density Microarray Patches (HD-MAPs): Challenges in Replacing the Needle and Syringe

10 September 2018 15:55 - 16:30

Case study - Formulation of split virus influenza vaccine antigen with CAPTISOL in combination with a polymer HD-MAP device for enhanced thermostability and immunogenicity

Dr. Angus Forster, Chief Development and Operations Officer, Vaxxas